Results
|
41.
|
|
|
42.
|
|
|
43.
|
|
|
44.
|
|
|
45.
|
|
|
46.
|
|
|
47.
|
|
|
48.
|
|
|
49.
|
The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway. [electronic resource] by
- Silginer, M
- Burghardt, I
- Gramatzki, D
- Bunse, L
- Leske, H
- Rushing, E J
- Hao, N
- Platten, M
- Weller, M
- Roth, P
Producer: 20170911
In:
Oncogene vol. 35
Availability: No items available.
|
|
50.
|
|
|
51.
|
|
|
52.
|
Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model. [electronic resource] by
- Sanchez-Macedo, N
- Feng, J
- Faubert, B
- Chang, N
- Elia, A
- Rushing, E J
- Tsuchihara, K
- Bungard, D
- Berger, S L
- Jones, R G
- Mak, T W
- Zaugg, K
Producer: 20130911
In:
Cell death and differentiation vol. 20
Availability: No items available.
|
|
53.
|
Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study. [electronic resource] by
- Gramatzki, D
- Roth, P
- Rushing, E J
- Weller, J
- Andratschke, N
- Hofer, S
- Korol, D
- Regli, L
- Pangalu, A
- Pless, M
- Oberle, J
- Bernays, R
- Moch, H
- Rohrmann, S
- Weller, M
Producer: 20191112
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|
|
54.
|
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. [electronic resource] by
- Wirsching, H-G
- Tabatabai, G
- Roelcke, U
- Hottinger, A F
- Jörger, F
- Schmid, A
- Plasswilm, L
- Schrimpf, D
- Mancao, C
- Capper, D
- Conen, K
- Hundsberger, T
- Caparrotti, F
- von Moos, R
- Riklin, C
- Felsberg, J
- Roth, P
- Jones, D T W
- Pfister, S
- Rushing, E J
- Abrey, L
- Reifenberger, G
- Held, L
- von Deimling, A
- Ochsenbein, A
- Weller, M
Producer: 20191112
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|